Trademark Search  /  CONFOCHIMER

CONFOCHIMER

● Live · Registered

U.S. federal trademark · Serial No. 97157176 · Reg. No. 018578363

Mark
CONFOCHIMER
Status
Registered
Serial Number
97157176
Registration No.
018578363
Filing Date
October 15, 2021
Registration Date
March 2, 2022
Class(es)
Class 001, Class 042

Owners

CONFO THERAPEUTICS NV
32 · GENT, BE
Confo Therapeutics N.V.
99 · Zwijnaarde, BE
Confo Therapeutics N.V.
99 · Zwijnaarde, BE
Confo Therapeutics N.V.
99 · Zwijnaarde, BE

Goods & Services

Medical and pharmacological research services; Pharmaceutical drug development services; Laboratory research services relating to pharmaceuticals; Research and development of vaccines and medicines; Scientific research for medical purposes and the development of pharmaceutical preparations in the area of chimeric proteins, antibodies for stabilization of proteins and G protein-coupled receptors (GPCRs)

Laboratory chemicals for scientific use; biochemicals for in vitro and in vivo scientific use; biochemical substances, namely, antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories; reagents for medical research; diagnostic preparations for scientific or research use; chemical reagents for use in genetic research; receptors and reagents for testing for G protein-coupled receptors (GPCRs); Chemical substances for use in the production of drugs; Biochemical and chemical substances and chemical reagents for measuring combined or divided natural and non-natural G protein-coupled receptors (GPCRs); Proteins for use in science; Chimeric proteins to measure, test and develop compounds and ligands binding to G protein-coupled receptors (GPCRs)

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "CONFOCHIMER" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.